Operating Income (Loss) in USD of Kairos Pharma, LTD. from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kairos Pharma, LTD. quarterly/annual Operating Income (Loss) history and change rate from Q3 2023 to Q3 2025.
  • Kairos Pharma, LTD. Operating Income (Loss) for the quarter ending September 30, 2025 was -$1.44M, a 275% decline year-over-year.
  • Kairos Pharma, LTD. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$5.61M.
  • Kairos Pharma, LTD. annual Operating Income (Loss) for 2024 was -$2.34M, a 36.7% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Kairos Pharma, LTD. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$5.61M -$1.44M -$1.05M -275% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$4.56M -$1.46M -$1.23M -556% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 -$3.32M -$1.27M -$979K -341% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 -$2.34M -$1.45M Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 -$383K -$96K -33.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$222K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 -$287K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q3 2023 -$287K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14

Kairos Pharma, LTD. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2.34M -$629K -36.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$1.71M Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.